|
Trends in Bio/Pharmaceutical Industry
Volume 5 / Issue 4 / 2009 (download whole issue) Letter from Editor
Letter from Editor  Yingfei Wei
Special Report
“Long Live”, the 2009 Nobel Prize - Report on 2009 Nobel Prize for Medicine
 Guoliang Yu
Biosimilars
Current Considerations for Biosimilar Therapeutics  Brent R. Williams and David Wenyan Shen
CMC Issues and Regulatory Requirements for Biosimilars  Bao-lu Chen
Biosimilar Legislation and its Impact on IP Protection  Tracy Huang, Zheng Liu, Elizabeth Howard, and Deborah Fishman
On the Brink of Accelerated Growth: Perspectives on Venture CapitalInvestment in Biosimilar  Jonathan C. Wang
Society Event
China’s Biomedical Industry: innovation and collaboration blossom: A Report on Hua-Chuang-Hui Grand-Pharma International Bio-Forum  Qinglin Che
The 5th Annual SABPA Pacific Forum on Life Science Alliances 
The Nuts, Bolts, and Best Practices in IND Filing - Report of CABS Preclinical Development and IND Filing Workshop 
CABA 2009 Annual Conference Report: Featuring Biomedical Innovation and US-China Partnership  William YongZhong Wang
Advertisement
Cellex 
Pharmaron 
Azopharma 
Genscript 
|











|